Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 1, 2024BMJOpen Access

P46 Management of autoimmune haemolytic anaemia in a paediatric patient

View Full Paper
Ask AI
Bookmark
Share

Authors

KYKa Yu YungSTS. Lin TsaiKRKalindi Rajani

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Yung et al. (2024) studied this question.

synapsesocial.com/papers/68e6c32cb6db643587641ebahttps://doi.org/10.1136/bmjpo-2024-nppg.56
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Efficacy of daratumumab in treatment of relapsed and/or refractory warm autoimmune hemolytic anemia in children2025
  2. 2“Bortezomib as Plasma Cell – Directed Therapy in Pediatric Refractory Autoimmune Haemolytic Anaemia: A Report of two cases ”2026
  3. 3Time for newer approach in age-old AIHA: Daratumumab?2024
  4. 4Posttransplant Autoimmune Hemolytic Anemia with Anti-D Specificity Successfully Treated with Daratumumab: A Case Report2024 · 3 citations
  5. 5AB1372 PEDIATRIC AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION IN TREATMENT-RESISTANT AUTOIMMUNE DISEASES: A REAL-LIFE SINGLE-CENTER EXPERIENCE2024 · 1 citations